Copyright
©The Author(s) 2025.
World J Gastroenterol. Feb 7, 2025; 31(5): 101280
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.101280
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.101280
Table 1 General clinical characteristics of patients with gastrointestinal schwannomas (n = 229), n (%)
Variable | Overall |
Age, year, median (IQR) | 56.00 (48.00, 63.00) |
Tumor size, cm, median (IQR) | 2.75 (1.80, 4.03) |
Duration of follow-up, month, median (IQR) | 13.78 (5.53, 30.60) |
Sex | |
Female | 148 (64.6) |
Male | 81 (35.4) |
Year of diagnosis | |
2007-2013 | 32 (14.0) |
2014-2019 | 83 (36.2) |
2020-2024 | 114 (49.8) |
Tumor location | |
Esophagus | 23 (10.0) |
Esophagus (unspecified site) | 3 (1.3) |
Upper esophagus | 5 (2.2) |
Middle esophagus | 6 (2.6) |
Lower esophagus | 9 (3.9) |
Stomach | 176 (76.9) |
Stomach (unspecified site) | 35 (15.3) |
Gastric cardia | 3 (1.3) |
Gastric fundus | 16 (7.0) |
Gastric body | 94 (41.0) |
Gastric angle | 3 (1.3) |
Gastric antrum | 25 (10.9) |
Intestines | 30 (13.1) |
Duodenum | 2 (0.9) |
Ascending colon | 8 (3.5) |
Transverse colon | 6 (2.6) |
Descending colon | 3 (1.3) |
Sigmoid colon | 3 (1.3) |
Rectum | 8 (3.5) |
- Citation: Zhang PC, Wang SH, Li J, Wang JJ, Chen HT, Li AQ. Clinicopathological features and treatment of gastrointestinal schwannomas. World J Gastroenterol 2025; 31(5): 101280
- URL: https://www.wjgnet.com/1007-9327/full/v31/i5/101280.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i5.101280